Cargando…
Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
Autores principales: | Gourgari, Evgenia A., Mete, Mihriye, Sampson, Maureen L., Harlan, David M., Remaley, Alan T., Rother, Kristina I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481982/ https://www.ncbi.nlm.nih.gov/pubmed/28515131 http://dx.doi.org/10.2337/dc16-2602 |
Ejemplares similares
-
Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018) -
3065 A1BG and ITIH4 proteins are upregulated on HDL of youth with type 1 diabetes and correlate with glycemic control
por: Gourgari, Evgenia, et al.
Publicado: (2019) -
Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study
por: Gourgari, Evgenia, et al.
Publicado: (2019) -
Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
por: Sarkar, Gayatri, et al.
Publicado: (2014) -
Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes
por: Rother, Kristina I., et al.
Publicado: (2009)